Relesium
Retail brand
- Products tracked
- 1
- Product claims
- 1
Overview
What Relesium covers.
Relesium is a dietary supplement formulated specifically to alleviate gastrointestinal side effects, such as constipation and bloating, associated with the use of GLP-1 receptor agonist medications. The product utilizes a patented blend of bovine colostrum and egg-derived immunoglobulins to support gut health and microbiome stability. It is marketed toward individuals undergoing GLP-1 therapy who seek to manage digestive discomfort while maintaining their treatment regimen.
- Talio tracks 1 product for Relesium.
- Positioned as a challenger brand.
- Tracked products include relesium glp-1 digestive support multi-symptom relief powder - 635oz25 servings.
- Products carry claims including Natural Ingredients.
- Headquartered in United States.
- Talio tracks 9,184 food and beverage companies headquartered or distributing in United States. Browse Companies in United States
- Talio tracks 7,736 food and beverage brands headquartered or distributing in United States. Browse Brands in United States
- Talio tracks 763 food and beverage companies with products in Prebiotic & Fibre Powders. Browse Companies in Prebiotic & Fibre Powders
Products
1 of 1 products Talio tracks for Relesium.
relesium glp-1 digestive support multi-symptom relief powder - 635oz25 servings
Product claims
FAQ
Questions this page answers.
What does Relesium do?
Relesium is a food and beverage brand based in United States, tracked in Talio's food and beverage intelligence platform.
What products does Relesium make?
Talio tracks 1 product for Relesium, including relesium glp-1 digestive support multi-symptom relief powder - 635oz25 servings.
What claims do Relesium products carry?
Talio tracks 1 marketing claim across Relesium products, including Natural Ingredients.
Is this the full Talio record?
No. This page is a public preview; proprietary metrics and workflow features remain inside authenticated Talio.
Proprietary metrics remain in authenticated Talio.
